RBC Bioscience Corporation (TPEX:6848)
Taiwan · Delayed Price · Currency is TWD 19.60
+0.25 (1.29%)
Jul 22, 2026, 12:49 PM CST
RBC Bioscience Market Cap
RBC Bioscience has a market cap or net worth of 279.76 million as of July 22, 2026. Its market cap has increased by 13.18% in one year.
Market Cap
279.76M
Enterprise Value
634.49M
Revenue
219.71M
Ranking
n/a
PE Ratio
11.95
Stock Price
19.60
ChartMarket Cap Chart
Since October 25, 2021, RBC Bioscience's market cap has decreased from 632.27M to 279.76M, a decrease of -55.75%. That is a compound annual growth rate of -15.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 279.76M | 16.32% |
| Dec 31, 2025 | 240.51M | -2.96% |
| Dec 31, 2024 | 247.83M | 17.90% |
| Dec 29, 2023 | 210.20M | 2.21% |
| Dec 30, 2022 | 205.66M | -55.24% |
| Dec 30, 2021 | 459.45M | -27.33% |
| Oct 25, 2021 | 632.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Advance Bio-Pharmaceutical | 899.10M |
| NatureWise Biotech & Medicals | 825.06M |
| BioLASCO Taiwan | 760.68M |
| Neith | 710.20M |
| MegaPro Biomedical | 708.69M |
| SynCore Biotechnology Co.,Ltd | 682.19M |
| Vectorite Biomedical | 564.65M |
| TaiwanJ Pharmaceuticals | 556.85M |